| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 89/05/03 | 95/06/09 | 郭憲壽 | 郭憲壽 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| -0.88(Q2) | 0 | 2.36 | 2.07% |
| 實收資本額 | 已發行普通股 | ||
| 5,601,624,740 | 560,162,474 | ||
| 主要經營業務 | |||
| 新藥開發 | |||
| 公司網址 | |||
| twmicrobio.com/ | |||
中天(4128) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 135,930 | 128,625 | 6.8% | 5.7% | 1,017,682 | 1,143,890 | -11% |
| 2023/07 | 127,215 | 129,957 | 11.2% | -2.1% | 881,752 | 1,015,265 | -13.1% |
| 2023/06 | 114,358 | 135,027 | -3.4% | -15.3% | 754,537 | 885,308 | -14.8% |
| 2023/05 | 118,371 | 150,306 | -11.8% | -21.2% | 640,179 | 750,281 | -14.7% |
| 2023/04 | 134,222 | 197,972 | -5.9% | -32.2% | 521,808 | 599,975 | -13% |
| 2023/03 | 142,696 | 132,714 | 35.2% | 7.5% | 387,586 | 401,991 | -3.6% |
| 2023/02 | 105,519 | 109,685 | -24.3% | -3.8% | 244,890 | 269,277 | -9.1% |
| 2023/01 | 139,371 | 159,592 | -2% | -12.7% | 139,371 | 159,592 | -12.7% |
| 2022/12 | 142,174 | 140,016 | -7.3% | 1.5% | 1,721,860 | 1,782,056 | -3.4% |
| 2022/11 | 153,294 | 153,615 | -0.8% | -0.2% | 1,579,686 | 1,642,040 | -3.8% |
| 2022/10 | 154,498 | 149,371 | 20.7% | 3.4% | 1,426,392 | 1,488,425 | -4.2% |
| 2022/09 | 128,004 | 148,292 | -0.5% | -13.7% | 1,271,894 | 1,339,054 | -5% |
| 2022/08 | 128,625 | 152,871 | -1% | -15.9% | 1,143,890 | 1,190,762 | -3.9% |
| 2022/07 | 129,957 | 158,157 | -3.8% | -17.8% | 1,015,265 | 1,037,891 | -2.2% |
| 2022/06 | 135,027 | 180,419 | -10.2% | -25.1% | 885,308 | 879,304 | 0.7% |
| 2022/05 | 150,306 | 183,613 | -24.1% | -18.1% | 750,281 | 698,885 | 7.3% |
| 2022/04 | 197,972 | 122,641 | 49.2% | 61.4% | 599,975 | 515,272 | 16.4% |
| 2022/03 | 132,714 | 141,507 | 21% | -6.2% | 401,991 | 392,631 | 2.4% |
| 2022/02 | 109,685 | 118,906 | -31.3% | -7.8% | 269,277 | 251,124 | 7.2% |
| 2022/01 | 159,592 | 132,218 | 14% | 20.7% | 159,592 | 132,218 | 20.7% |
| 2021/12 | 140,016 | 134,134 | -8.9% | 4.4% | 1,782,056 | 1,601,223 | 11.3% |
| 2021/11 | 153,615 | 142,513 | 2.8% | 7.8% | 1,642,040 | 1,467,089 | 11.9% |
| 2021/10 | 149,371 | 128,972 | 0.7% | 15.8% | 1,488,425 | 1,324,734 | 12.4% |
| 2021/09 | 148,292 | 138,067 | -3% | 7.4% | 1,339,054 | 1,197,961 | 11.8% |
| 2021/08 | 152,871 | 135,405 | -3.3% | 12.9% | 1,190,762 | 1,059,894 | 12.3% |
| 2021/07 | 158,157 | 116,238 | -12.3% | 36.1% | 1,037,891 | 924,489 | 12.3% |
| 2021/06 | 180,419 | 119,129 | -1.7% | 51.4% | 879,304 | 808,251 | 8.8% |
| 2021/05 | 183,613 | 122,116 | 49.7% | 50.3% | 698,885 | 689,122 | 1.4% |
| 2021/04 | 122,641 | 150,372 | -13.3% | -18.4% | 515,272 | 567,006 | -9.1% |
| 2021/03 | 141,507 | 152,975 | 19% | -7.5% | 392,631 | 416,634 | -5.8% |
| 2021/02 | 118,906 | 132,948 | -10.1% | -10.6% | 251,124 | 263,659 | -4.8% |
| 2021/01 | 132,218 | 130,711 | -1.4% | 1.1% | 132,218 | 130,711 | 1.1% |
| 2020/12 | 134,134 | 121,622 | -5.9% | 10.3% | 1,601,223 | 1,466,303 | 9.2% |
| 2020/11 | 142,513 | 144,200 | 10.5% | -1.2% | 1,467,089 | 1,344,681 | 9.1% |
| 2020/10 | 128,972 | 140,701 | -6.6% | -8.3% | 1,324,734 | 1,200,481 | 10.4% |
| 2020/09 | 138,067 | 119,971 | 2% | 15.1% | 1,197,961 | 1,059,780 | 13% |
中天(4128) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | -5.32% | -6.81% | 2020Q3 | -0.49% | 1.64% |
| 2023Q1 | -13.86% | -0.84% | 2020Q2 | -6.00% | 2.79% |
| 2022Q4 | 16.39% | 0.41% | 2020Q1 | 2.49% | 4.73% |
| 2022Q3 | -20.01% | -4.07% | 2019Q4 | 11.75% | 0.26% |
| 2022Q2 | 20.23% | -0.19% | 2019Q3 | 4.32% | 1.30% |
| 2022Q1 | -9.26% | 0.53% | 2019Q2 | 0.43% | -0.47% |
| 2021Q4 | -3.55% | 2.14% | 2019Q1 | -13.78% | 0.17% |
| 2021Q3 | -5.62% | 4.16% | 2018Q4 | 16.73% | 0.84% |
| 2021Q2 | 23.95% | 6.02% | 2018Q3 | -2.97% | -0.04% |
| 2021Q1 | -3.20% | -1.50% | 2018Q2 | 3.13% | 1.09% |
| 2020Q4 | 4.08% | -0.06% | 2018Q1 | -11.76% | 0.60% |
評論0